BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1843059)

  • 1. Treatment of advanced non-Hodgkin's lymphoma in adults.
    Friedenberg WR
    Wis Med J; 1991 Dec; 90(12):676-8. PubMed ID: 1843059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse aggressive lymphomas: a curable subset of non-Hodgkin's lymphomas.
    Skarin AT
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):10-25. PubMed ID: 2432666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
    Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of allogeneic transplantation in non-Hodgkin's lymphoma.
    Peggs KS; Mackinnon S; Linch DC
    Br J Haematol; 2005 Jan; 128(2):153-68. PubMed ID: 15638849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of high risk non-Hodgkin's lymphoma].
    Sawada U
    Rinsho Ketsueki; 1993 Apr; 34(4):403-10. PubMed ID: 7685431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
    Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
    Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
    Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hodgkin's lymphoma associated with the acquired immunodeficiency syndrome.
    Cáceres W
    Bol Asoc Med P R; 1995; 87(10-12):158-61. PubMed ID: 8924158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients.
    Addeo R; Caraglia M; Costanzo R; Faiola V; Montella L; Abbruzzese A; Del Prete S
    Oncol Rep; 2004 Jul; 12(1):135-40. PubMed ID: 15201974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approaches to the treatment of advanced-stage non-Hodgkin's lymphoma.
    Rusthoven JJ
    CMAJ; 1987 Jan; 136(1):29-36. PubMed ID: 3539298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of non-Hodgkin's lymphoma.
    Jones JM
    J Med Assoc Ga; 1989 Feb; 78(2):105-8. PubMed ID: 2918256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
    Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
    Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
    Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
    Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-Hodgkin's lymphomas associated with the acquired immunodeficiency syndrome. A multicenter clinical study of 77 cases].
    Rubio R; Pulido F; Pintado V; Díaz-Mediavilla J; Flores E; Serrano M; Alberdi JC; López-Gay D; Verdejo J; Barros C
    Med Clin (Barc); 1995 Apr; 104(13):481-6. PubMed ID: 7746011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS-associated lymphomas.
    Kaplan LD
    Infect Dis Clin North Am; 1988 Jun; 2(2):525-32. PubMed ID: 3060534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.